Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bruce Ferguson

JAMA

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|February 8, 2007
Aprotinin--are there lessons learned?T Bruce Ferguson
JAMA|May 1, 2002
Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North AmericaT Bruce Ferguson, Laura P Coombs, Eric D Peterson, et al.
JAMA|January 15, 2004
Procedural volume as a marker of quality for CABG surgeryEric D Peterson, Laura P Coombs, Elizabeth R DeLong, et al.
JAMA|July 3, 2003
Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trialT Bruce Ferguson, Eric D Peterson, Laura P Coombs, et al.
JAMA|August 19, 2010
Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trialElliott Bennett-Guerrero, T Bruce Ferguson, Min Lin, et al.
JAMA|November 17, 2005
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trialJohn H Alexander, Gail Hafley, Robert A Harrington, et al.
JAMA|July 12, 2012
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trialMark F Newman, T Bruce Ferguson, Jennifer A White, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|February 8, 2007
Aprotinin--are there lessons learned?T Bruce Ferguson
JAMA|May 1, 2002
Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North AmericaT Bruce Ferguson, Laura P Coombs, Eric D Peterson, et al.
JAMA|January 15, 2004
Procedural volume as a marker of quality for CABG surgeryEric D Peterson, Laura P Coombs, Elizabeth R DeLong, et al.
JAMA|July 3, 2003
Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trialT Bruce Ferguson, Eric D Peterson, Laura P Coombs, et al.
JAMA|August 19, 2010
Effect of an implantable gentamicin-collagen sponge on sternal wound infections following cardiac surgery: a randomized trialElliott Bennett-Guerrero, T Bruce Ferguson, Min Lin, et al.
JAMA|November 17, 2005
Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trialJohn H Alexander, Gail Hafley, Robert A Harrington, et al.
JAMA|July 12, 2012
Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trialMark F Newman, T Bruce Ferguson, Jennifer A White, et al.
Pageof 1